GLP-1 medications are prescription medications that require evaluation by a licensed clinician
While tirzepatide is not currently approved to reduce the risk of major adverse cardiovascular events (MACE), an ongoing cardiovascular outcomes trial (SURPASS-CVOT) is investigating this, with results expected soon
A letter of medical necessity is a short note from a licensed provider, whether thats your primary care provider, a nurse practitioner, even your OB-GYN, confirming that you have a real diagnosis and that your GLP-1 is treating an actual medical condition, not a wellness whim
The Journal of Endocrinology, 249 (2), 7182
When people stop semaglutide, they typically regain most of the lost weight within 6-12 months
If you believe in what we do and support our mission, please donate today .